KEITH WEBSTER to Genetic Therapy
This is a "connection" page, showing publications KEITH WEBSTER has written about Genetic Therapy.
Connection Strength
0.832
-
Vascular Regeneration in Ischemic Hindlimb by Adeno-Associated Virus Expressing Conditionally Silenced Vascular Endothelial Growth Factor. J Am Heart Assoc. 2016 05 26; 5(6).
Score: 0.340
-
Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther. 2005 May; 12(9):762-71.
Score: 0.158
-
Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody. Gene Ther. 2024 11; 31(11-12):587-593.
Score: 0.151
-
Gene and cell therapy for heart disease. IUBMB Life. 2002 Aug; 54(2):59-66.
Score: 0.130
-
Therapeutic angiogenesis: a case for targeted, regulated gene delivery. Crit Rev Eukaryot Gene Expr. 2000; 10(2):113-25.
Score: 0.027
-
Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway. J Am Coll Cardiol. 2019 06 04; 73(21):2705-2718.
Score: 0.026